부메뉴
USP-NF 해당 칼럼 찾기
USP-NF Monograph | Column | ||
---|---|---|---|
L32 | A chiral ligand-exchange resin packing-L-proline copper complex covalently bonded to irregularly shaped silica particles, 5 to 10 μm in diameter | Chiralpak WH |
|
L40 | Cellulose tris-3,5-dimethylphenylcarbamate coated porous silica particles, 5 - 20 µm in diameter. | Chiralcel OD Chiralcel OD-H |
|
1 | Amlodipine and Valsartan Tablets | ||
2 | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets | ||
3 | Atomoxetine Hydrochloride | ||
4 | Duloxetine Hydrochloride | ||
5 | Efavirenz | ||
6 | Eszopiclone | ||
7 | Irinotecan Hydrochloride | ||
8 | Sertraline Hydrochloride | ||
9 | Tiagabine Hydrochloride | ||
10 | Timolol Maleate | ||
11 | Valsartan | ||
12 | (+)-1-(9-Fluorenyl)ethyl Chloroformate Solution | ||
13 | Rotigotine (2019.12.01 ~ ) | ||
L41 | Immobilized alfa1-acid glycoprotein on spherical silica particles, 5 µm in diameter. | Chiral AGP | |
1 | Benazepril Hydrochloride | ||
2 | Dexmedetomidine Hydrochloride | ||
3 | Esomeprazole Magnesium | ||
4 | Esomeprazole Magnesium Delayed-Release Capsules | ||
5 | Esomeprazole Strontium | ||
6 | Fentanyl Citrate and Ropivacaine | ||
7 | Galantamine Hydrobromide | ||
8 | Montelukast Sodium | ||
9 | Repaglinide | ||
10 | Rivastigmine Tartrate | ||
11 | Ropivacaine Hydrochloride Injection | ||
12 | Tolterodine Tartrate | ||
L51 | Amylose tris-3,5-dimethylphenylcarbamate-coated, porous, spherical, silica partilces, 5 to 10 µm in diameter. | Chiralpak AD Chiralpak AD-H |
|
1 | Abacavir Sulfate | ||
2 | Aprepitant | ||
3 | Atorvastatin Calcium | ||
4 | Brinzolamide | ||
5 | Brinzolamide Ophthalmic Suspension | ||
6 | Dexchlorpheniramine Maleate | ||
7 | Fulvestrant | ||
8 | Levetiracetam | ||
9 | Linezolid | ||
10 | Paroxetine Hydrochloride | ||
11 | Pramipexole Dihydrochloride | ||
12 | Sitagliptin Phosphate | ||
13 | Tadalafil | ||
14 | Tamsulosin Hydrochloride | ||
15 | Aztec Marigold Zeaxanthin Extract | ||
16 | Metaraminol Bitartrate (2019.12.01 ~ ) | ||
17 | meso-Zeaxanthin | ||
18 | meso-Zeaxanthin Preparation | ||
L66 | A crown ether coated on a 5 µm particle size silica gel substrate. The active site is (S)-18-crown-6-ether. | Crownpak CR (+) | |
1 | Valacyclovir hydrochloride | ||
2 | Valacyclovir Tablets | ||
3 | Valganciclovir Hydrochloride | ||
L70 | Cellulose tris(phenyl carbamate) coated on 5 µm silica. | Chiralcel OC-H | |
1 | Oxaliplatin | ||
L75 | A chiral-recognition protein, bovine serum albumine (BSA), chemically bonded to silica particles, about 7 2µm in diameter, with a pore size of 300 Angstroms. | Chiralpak BSA | |
1 | Methorexate | ||
L79 | A chiral-recognition protein, human serum albumin (HSA), chemically bonded to silica particles, about 5 µm in diameter. | Chiralpak HSA | |
1 | Calcium l-5-Methyltetrahydrofolate | ||
2 | Calcium l-5-Methyltetrahydrofolate Capsules | ||
3 | Calcium l-5-Methyltetrahydrofolate Tablets | ||
L80 | Cellulose tris(4-methylbenzoate)-coated, porous, spherical, silica particles, 5 - 20 µm in diameter. | Chiralcel OJ Chiralcel OJ-H |
|
1 | Clopidogrel bisulfate | ||
2 | Exemestane | ||
3 | Benzphetamine Hydrochloride (2019.08.01 ~ ) | ||
L90 | Amylose tris-[(S)-alpha-methylbenzylcarbamate] coated on porous, spherical silica particles, 3 to 10 µm in diameter. | Chiralpak AS Chiralpak AS-H Chiralpak AS-3 |
|
1 | Levocetirizine Dihydrochloride | ||
L93 | Cellulose tris(3,5-dimethylpheylcarbamate) reversed phase chiral stationary phase coated on 3 or 5 22m silica gel particles. | Chiralcel OD-R Chiralcel OD-3R |
|
1 | Ezetimibe | ||
L99 | Amylose tris-(3,5)-dimethylphenylcarbamate), immobilized on porous, spherical, silica particles, 3 to 5 22m in diameter. | Chiralpak IA Chiralpak IA-3 |
|
L107 | Cellulose tris(4-methylbenzoate)-coated porous spherical particles, 3 to 5 µm in diameter, for use with reversed phase mobile phases. | Chiralcel OJ-RH |
|
1 | Rosuvastatin calcium | ||
L108 | A chiral-recognition protein, cellobiohydrolase (CBH), chemically bonded to silica particles, about 5 µm in diameter. | Chiralpak CBH |
|
1 | Epinephrine (2019.12.01 ~ ) | ||
L117 | A crown ether coated on a 5 μm particle size silica gel substrate. The active site is (R)-18-crown-6-ether. | CROWNPAK CR(-) |
|
L119 | Cellulose tris-(3,5-dichlorophenylcarbamate), immobilized on porous, spherical, silica particles, 3 to 5 µm in diameter. | CHIRALPAK IC Chiralpak IC-3 |
|
L## | (Latanoprost, Chiracel OD-R) - Cellulose tris(3,5-dimethylphenylcarbamate) coated on 10 μm silica gel particles. | CHIRALCEL OD-R |
|